Brenda Schulman is an American biochemist and structural biologist who is a Director at the Max Planck Institute of Biochemistry, Martinsried, Bavaria.

[2] Schulman received her bachelor's degree in biology from Johns Hopkins University in 1989 and her PhD in biology from the Massachusetts Institute of Technology in 1996, advised by Peter S. Kim.

She then worked as a postdoctoral fellow with Ed Harlow at the Massachusetts General Hospital Cancer Center and later with Nikola Pavletich at the Memorial Sloan Kettering Cancer Center.

[1][2][3] After sixteen years at St. Jude's, Schulman moved to the Max Planck Institute in 2017.

[1] Schulman's research career has focused on the effects of post-translational modifications on the regulation of proteins in eukaryotic cells.